<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03364946</url>
  </required_header>
  <id_info>
    <org_study_id>CCEI-7327-2017</org_study_id>
    <nct_id>NCT03364946</nct_id>
  </id_info>
  <brief_title>High Flow Therapy in ICUs Across Ibero America</brief_title>
  <acronym>T-Calfi</acronym>
  <official_title>High Flow Nasal Cannula Technique in Iberoamerica</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Santa Fe de Bogota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Santa Fe de Bogota</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to describe the use of Nasal High Flow (NHF) in the intensive care units of
      participating centers in Iberoamerica. It will describe the indications for the use, the
      clinical outcome of patients , and the therapeutic failure of NHF therapy in patients staying
      in an intensive care unit in the participant centers in Iberoamerica.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 15, 2018</start_date>
  <completion_date type="Anticipated">December 15, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>15 Days</target_duration>
  <primary_outcome>
    <measure>Hypoxemia</measure>
    <time_frame>15 days</time_frame>
    <description>PO2 under 60mmHg, or SatO2 under 80%; that leads to the instauration of invasive ventilation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tachypnea</measure>
    <time_frame>15 days</time_frame>
    <description>Respiratory rate over 20; that leads to the instauration of invasive ventilation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hypercapnia</measure>
    <time_frame>15 days</time_frame>
    <description>PCO2 over 55mmHg; that leads to the instauration of invasive ventilation</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">422</enrollment>
  <condition>Nasal High Flow Therapy</condition>
  <condition>Intensive Care Unit</condition>
  <condition>Ventilatory Failure</condition>
  <condition>Hypoxia</condition>
  <condition>Hypercapnic Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>High Nasal Flow Therapy</arm_group_label>
    <description>Every patient in the ICU that requires High Nasal Flow Therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention, observational study</description>
    <arm_group_label>High Nasal Flow Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 18 years old, admitted to an ICU in the reference centers in Iberoamerica,
        requiring the use of high nasal flow therapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 years old

          -  Admitted to medical or surgical ICU

          -  Requirement of high nasal flow therapy

        Exclusion Criteria:

          -  Post-extubation failure

          -  Patient unable to protect airway

          -  Diagnosed shock

          -  Glasgow equal or under 8
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leopoldo E Ferrer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundación Santa Fe de Bogotá</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leopoldo E Ferrer, MD</last_name>
    <phone>5716030303</phone>
    <phone_ext>5016</phone_ext>
    <email>lfanesthesia@gmail.com</email>
  </overall_contact>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2017</study_first_submitted>
  <study_first_submitted_qc>December 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 7, 2017</study_first_posted>
  <last_update_submitted>December 1, 2017</last_update_submitted>
  <last_update_submitted_qc>December 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundación Santa Fe de Bogota</investigator_affiliation>
    <investigator_full_name>Leopoldo Ferrer</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
    <mesh_term>Hypoventilation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No IPD will be available to external researchers prior to publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

